These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6124026)

  • 1. The beta-adrenomimetic activity of tetrahydroisoquinolines and tetrahydronaphthalenes.
    Beaumont D; Waigh RD
    Prog Med Chem; 1981; 18():45-86. PubMed ID: 6124026
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of dihydroxy-2-aminotetraline (DATs) on dopamine and beta type adenylate cyclases.
    Sheppard H; Burghardt CR; Long JP
    Res Commun Chem Pathol Pharmacol; 1978 Feb; 19(2):213-24. PubMed ID: 205926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the structure-activity relationship of adrenergic beta-mimetic benzylamine derivatives. IV.1) Aryl-substituted 1-aminotetralins and 1-aminoindans.
    Yamamura S; Oda K; Mizoguchi T; Saito S; Iwasawa Y; Ohashi M; Kiyomoto A
    Chem Pharm Bull (Tokyo); 1978 Dec; 26(12):3613-23. PubMed ID: 34486
    [No Abstract]   [Full Text] [Related]  

  • 4. Substituted 1,2,3,4-tetrahydroaminonaphthols: antihypertensive agents, calcium channel blockers, and adrenergic receptor blockers with catecholamine-depleting effects.
    Atwal KS; O'Reilly BC; Ruby EP; Turk CF; Aberg G; Asaad MM; Bergey JL; Moreland S; Powell JR
    J Med Chem; 1987 Apr; 30(4):627-35. PubMed ID: 2435902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catecholaminergic involvement in the biphasic effect of ADATN on temperature in mice.
    Dooley DJ; Namkung MJ; Hungar AA; Horita A; Bowden DM
    Eur J Pharmacol; 1981 May; 71(2-3):269-76. PubMed ID: 7250189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Adrenomimetic activity of a derivative of 2-aminotetralin].
    Staneva D; Chakurova L; Raĭnova L
    Eksp Med Morfol; 1983; 22(4):42-7. PubMed ID: 6673968
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies on the structure activity relationship of adrenergic beta-mimetic benzylamine derivatives. II. 1-Alkylamino-2-phenyl-1,2,3,4-tetrahydronaphthalenes.
    Yamamura S; Saito S; Iwasawa Y; Ohashi M; Kiyomoto A
    Chem Pharm Bull (Tokyo); 1976 Dec; 24(12):3222-5. PubMed ID: 14787
    [No Abstract]   [Full Text] [Related]  

  • 8. Differentiation of alpha-adrenergic receptors using pharmacological evaluation and molecular modeling of selective adrenergic agents.
    Hancock AA; Kyncl JJ; Martin YC; DeBernardis JF
    J Recept Res; 1988; 8(1-4):23-46. PubMed ID: 2898529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereoselective interaction of tetrahydroisoquinolines in beta-adrenoceptor systems.
    Piascik MT; Osei-Gyimah P; Miller DD; Feller DR
    Eur J Pharmacol; 1978 Apr; 48(4):393-401. PubMed ID: 25778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of molecular size on 5-hydroxytryptamine receptor agonist activity of 8-hydroxy-2-(alkylamino)tetralins and adrenal cortical 11 beta-hydroxylase inhibition potency of metyrapone analogues.
    Singh P
    Arzneimittelforschung; 1986 Oct; 36(10):1437-9. PubMed ID: 3493010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conformational analysis of beta 2-adrenoceptor-stimulating agents.
    Motohashi M; Nishikawa M
    Mol Pharmacol; 1981 Jul; 20(1):22-7. PubMed ID: 6117002
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effects of dl-demethyl coclaurine on beta-adrenergic receptors and adenylate cyclase in turkey erythrocyte membrane].
    Feng YP; Jia HJ; Zhang LY; Zeng GY
    Yao Xue Xue Bao; 1982 Sep; 17(9):641-6. PubMed ID: 6130668
    [No Abstract]   [Full Text] [Related]  

  • 13. Dopamine agonists: structure-activity relationships.
    Cannon JG
    Prog Drug Res; 1985; 29():303-414. PubMed ID: 3911262
    [No Abstract]   [Full Text] [Related]  

  • 14. Structure-activity relationships of dopamine agonists.
    Cannon JG
    Annu Rev Pharmacol Toxicol; 1983; 23():103-29. PubMed ID: 6347047
    [No Abstract]   [Full Text] [Related]  

  • 15. Structure-binding-activity analysis of beta-adrenergic amines--I. Binding to the beta receptor and activation of adenylate cyclase.
    Bilezikian JP; Dornfeld AM; Gammon DE
    Biochem Pharmacol; 1978 May; 27(10):1445-54. PubMed ID: 29638
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of apomorphine, TL-99 and 3-PPP on yawning in rats.
    Mogilnicka E; Boissard CG; Delini-Stula A
    Neuropharmacology; 1984 Jan; 23(1):19-22. PubMed ID: 6144063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A study of the conformational requirements for direct adrenergic stimulation.
    Gray AP; Reit E; Ackerly JA; Hava M
    J Med Chem; 1973 Sep; 16(9):1023-7. PubMed ID: 4147657
    [No Abstract]   [Full Text] [Related]  

  • 18. The beta adrenergic receptors of rat corpus luteum membranes.
    Coleman AJ; Paterson DS; Somerville AR
    Biochem Pharmacol; 1979 Apr; 28(7):1003-10. PubMed ID: 36086
    [No Abstract]   [Full Text] [Related]  

  • 19. Discovery of L-755,507: a subnanomolar human beta 3 adrenergic receptor agonist.
    Parmee ER; Ok HO; Candelore MR; Tota L; Deng L; Strader CD; Wyvratt MJ; Fisher MH; Weber AE
    Bioorg Med Chem Lett; 1998 May; 8(9):1107-12. PubMed ID: 9871717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presence of both beta1- and beta2-adrenergic receptors in a single cell type.
    Homburger V; Lucas M; Rosenbaum E; Vassent G; Bockaert J
    Mol Pharmacol; 1981 Nov; 20(3):463-9. PubMed ID: 6120448
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.